Talk:Chronic eosinophilic leukemia

Imatinib
Imatinib is used in PDGFRA-FIL1P1 fusion, but it turns out that a very low weekly dose is sufficient: http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2141.2008.07033.x JFW | T@lk  11:06, 25 March 2008 (UTC)